Posted: Wed Apr 29, 2009 10:37 pm Post subject: Medicago initiates work on Swine Flu strain
30 Apr 2009 - Medicago Inc. announced that it has received a genetic sequence of the new strain of influenza A (H1N1) that has recently been identified in USA and Mexico, and has commenced laboratory work with its VLP vaccine technology to produce material for testing.
According to the World Health Organization ("WHO"), a genetic analysis shows this new flu strain is a never-before-seen mixture of swine, human and avian viruses and has the potential of becoming a pandemic.
The Company has already expressed VLPs of the following pandemic strains in plants: Singapore (H2N2), Anhui (H5N1), Vietnam (H5N1), Hong Kong (H6N1 and H9N2), Equine/Prague (H7N7), and of the seasonal strains New Caledonia (H1N1), Solomon Island (H1N1) and Brisbane (H1N1). Medicago is keeping health authorities informed on its work.
According to the company, Medicago's H5N1 pandemic VLP vaccine has shown to be immunogenic at doses as low as 5 micrograms in preclinical studies and provided 100% cross-protection to different strains of the H5N1 virus in an animal model.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum